Growth Hormone Therapy for Short Children Born Small for Gestational Age
- 7 September 2007
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 68 (6), 300-309
- https://doi.org/10.1159/000107935
Abstract
Children born small for gestational age may demonstrate continued growth retardation, resulting in persistent short stature. In the majority of the cases, this is linked with abnormal growth hormone secretion and also abnormal insulin-like growth factor levels. This review discusses the treatment of such children with recombinant human growth hormone. It illustrates the importance of starting therapy early, the dose-dependent response, and the advantages of continuous therapy and describes safety considerations.Keywords
This publication has 53 references indexed in Scilit:
- Intermittent Recombinant Growth Hormone Treatment in Short Children Born Small for Gestational Age: Four-Year Results of a Randomized Trial of Two Different Treatment RegimensHormone Research in Paediatrics, 2006
- Growth Hormone Treatment of Short Children Born Small for Gestational Age: Growth Responses with Continuous and Discontinuous Regimens Over 6 YearsJournal of Clinical Endocrinology & Metabolism, 2000
- Growth Hormone Treatment in Children with Short Stature Born Small for Gestational Age: 5-Year Results of a Randomized, Double-Blind, Dose-Response TrialJournal of Clinical Endocrinology & Metabolism, 1999
- Oncogenic ras Causes Resistance to the Growth Inhibitor Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) in Breast Cancer CellsPublished by Elsevier BV ,1999
- Insulin Resistance in Short Children with Intrauterine Growth RetardationJournal of Clinical Endocrinology & Metabolism, 1997
- Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational ageJournal of Clinical Endocrinology & Metabolism, 1996
- Growth hormone treatment of short children born small for gestational age or with Silver–Russell syndrome: results from KIGS (Kabi International Growth Study), including the first report on final heightActa Paediatrica, 1996
- Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. Belgian and French Pediatric Clinics and Sanofi-Choay (France)Journal of Clinical Endocrinology & Metabolism, 1994
- Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome, and intrauterine growth retardation during the first year of treatment with GHJournal of Clinical Endocrinology & Metabolism, 1994
- Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeksThe Journal of Pediatrics, 1969